|
Volumn , Issue , 2011, Pages
|
Treatment of polyglandular autoimmune syndrome type 3 using co-transplantation of insulin-secreting mesenchymal stem cells and haematopoietic stem cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BORTEZOMIB;
C PEPTIDE;
CYCLOPHOSPHAMIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
HEMOGLOBIN A1C;
INSULIN;
INSULIN DERIVATIVE;
LONG ACTING INSULIN;
RECOMBINANT HUMAN INSULIN;
RITUXIMAB;
SHORT ACTING DRUG;
SHORT ACTING INSULIN;
THYMOCYTE ANTIBODY;
THYROXINE;
UNCLASSIFIED DRUG;
ADIPOSE TISSUE CELL;
ADOLESCENT;
ADULT;
ARTICLE;
AUTOIMMUNE DISEASE;
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION;
CASE REPORT;
CLINICAL EFFECTIVENESS;
DISEASE DURATION;
FEMALE;
FOLLOW UP;
HUMAN;
HUMAN CELL;
HYPOTHYROIDISM;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN RELEASE;
LABORATORY TEST;
MALE;
MESENCHYMAL STEM CELL TRANSPLANTATION;
MULTIPLE ENDOCRINE ADENOMATOSIS;
PATIENT SAFETY;
POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE 3;
PORTAL VEIN BLOOD FLOW;
PRIORITY JOURNAL;
|
EID: 80053079524
PISSN: None
EISSN: 1757790X
Source Type: Journal
DOI: 10.1136/bcr.07.2011.4436 Document Type: Article |
Times cited : (5)
|
References (7)
|